AstraZeneca | Cafepharma
4 days ago · AstraZeneca has entered an agreement with China-based CSPC Pharmaceuticals to advance drug development programs targeting obesity and type 2 diabetes. The deal covers eight …
AstraZeneca | Cafepharma Message Boards | Pharma Sales, Device …
Dec 15, 2025 · Anonymous board for AstraZeneca. We’re running a short, anonymous survey to better understand how pharma reps (and others in the industry) are actually using AI today, what concerns …
AstraZeneca Seals $1.2B Obesity and Metabolic Disease Pipeline Deal ...
Feb 11, 2026 · AstraZeneca has entered an agreement with China-based CSPC Pharmaceuticals to advance drug development programs targeting obesity and type 2 diabetes. The deal covers eight …
January 14 2026 - JPM26: AstraZeneca's $80B revenue target 'very …
Jan 14, 2026 · Confidence is on full display at JPM, as companies talk up revenue targets, pipeline momentum, and dealmaking strength—tempered by ongoing regulatory and pricing realities.JPM26: …
Cafepharma News
AstraZeneca has entered an agreement with China-based CSPC Pharmaceuticals to advance drug development programs targeting obesity and type 2 diabetes. The deal covers eight programs, …
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Anonymous discussion boards for pharmaceutical sales, medical/device sales, lab/diagnostics sales
AstraZeneca sets sights on 25+ blockbusters by 2030 to fuel $80B ...
Feb 10, 2026 · After ending 2025 with a strong fourth quarter, AstraZeneca management has doubled down on its ambitious “$80 billion by 2030” revenue target, outlining a roadmap to have more than 25 …
Multiply Labs partners with AstraZeneca to automate cell therapy ...
Jan 27, 2026 · Multiply Labs Inc. today announced an agreement with AstraZeneca to evaluate the potential for applying good manufacturing practice, or GMP-ready, robotic systems to commercial …
Cafepharma - Home | pharma sales, device sales, lab sales | Cafepharma
4 days ago · Ambitious sales projections and sustained clinical remission data close the week on an optimistic note. Yet vaccine policy turbulence, legal action, and diagnostic setbacks highlight the …
AstraZeneca joins the DTC platform pack, offering up to 70% discounts ...
Sep 26, 2025 · AstraZeneca is the latest Big Pharma to unveil a digital direct-to-consumer platform offering certain medicines at heavily reduced prices to cash-pay patients. AstraZeneca Direct will go …